According to Morningstar, the iShares FTSE/Xinhua China 25 Index ETF (FXI) is not only one of the 25 most popular exchange-traded funds on the market today, it's also the most-traded China-focused ETF. Despite the volatile Chinese market, this ETF attracted a net $3 billion of inflows in 2008.
"That's great," you might think. "Investors are finally realizing that China is a place where they need to be invested." That might be true, but if so, they're going about it the wrong way.
Seriously red tape
Some investors confuse FXI with a proper way to invest in the Chinese growth story. That just isn't the case, for a variety of reasons.
By investing in FXI, you're not sufficiently tapping into the entrepreneurial spirit of the Chinese people. See, FXI tracks a FTSE/Xinhua index mainly comprising state-owned enterprises (SOEs). In fact, of the top 10 holdings of the exchange-traded fund, 10 are SOEs (or are subsidiaries of SOEs, which for my purposes are one and the same).
In terms of past performance, that hasn't been so bad. Despite the recent plunge in the Chinese markets, which has sent names like PetroChina
But while FXI holdings like Huaneng Power
A little background
SOEs have traditionally been the dominant players in the Chinese economy. In 1958, during the days of Chairman Mao, more than 97% of the Chinese economy was under the control of the government (PRC) through the use of SOEs.
Granted, things have changed over the past 50 years, following the economic reforms of Deng Xiaoping in the late 1970s and '80s. Today there are far fewer SOEs, but they still make up a significant chunk of China's gross domestic product and are mostly found in the energy, telecommunications, and financial sectors. The government keeps many of them alive by infusing them with capital, and one of the ways it does this is by -- wait for it -- taking them public.
The Chinese government has certainly reduced its ownership of some SOEs, but given the size of those companies and the size of the government's remaining ownership, it could be a long time before those SOEs are fully privatized. Just imagine if the PRC decided to suddenly dump its huge stake in China Life Insurance into the public markets. It would be an utter disaster for those shares.
The bottom line is that, despite the loosening of the PRC's grip, SOEs still do not put shareholder interests first. Their motivation is still at least partly political, so you're better off looking for Chinese companies that have your interests at heart.
This one will go to the hares
While the SOEs join the free markets at a tortoise's pace, non-SOE Chinese companies like Sohu.com, Mindray Medical, and New Oriental Education are flying by them in terms of innovation and ability to react to global economic movements. Moreover, these Chinese companies are led by entrepreneurs who represent the Chinese growth story. These, and not the SOEs, are the types of companies that may turn out to be some of the best stocks of the next 10 years.
For this reason, the Motley Fool Global Gains team is looking beyond the realm of Chinese SOEs. That's why the team made their second trip to China last year to meet with some of the country's most promising companies. The team also made stops in Vietnam, Indonesia, and Singapore. If you'd like to read their reports and take a peek at all the Global Gains recommendations, a free 30-day trial of the service is yours. Click here to get started.
This article was first published June 3, 2008. It has been updated.
Todd Wenning bets you he can throw a football over them mountains. He does not own shares of any company mentioned. Pfizer is a Motley Fool Inside Value selection. Huaneng Power International, Mindray Medical, and Sohu.com are Motley Fool Rule Breakers recommendations. New Oriental Education is a Motley Fool Global Gains selection. The Fool owns shares of Mindray Medical and has sold its stake in Pfizer. The Fool's disclosure policy has large talons.